Direct transfer to the angiography suite versus emergency department evaluation for suspected large vessel occlusion stroke
Official title: Delay Avoiding Primary Evaluation for Thrombectomy for Acute Stroke Patients With Large Vessel Occlusion in the Angiography Suite (DIRECT) Trial
Run by University of Iowa · NCT06825897 · Data updated 2026-11-12
This trial will see if taking adults with suspected large vessel occlusion stroke directly to the angiography suite instead of first evaluating them in the emergency department helps people recover better when they arrive within 7 hours of symptom onset.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2039 (estimated) |
| Sponsor | University of Iowa Academic / other |
| Locations | 15 sites (New Haven, Connecticut and 14 other locations) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT06825897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who present to a participating thrombectomy-capable center with signs suggestive of LVO stroke, a baseline NIHSS ≥ 10, and arrival within 7 hours of last known well are the ideal candidates.
✕Probably not a fit
Patients who arrive outside the 7-hour window, have low stroke severity, or who do not meet imaging or transfer timing criteria are unlikely to benefit from the direct-to-angio approach in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic randomized trial compares two triage strategies for adults with suspected large vessel occlusion (LVO) stroke presenting within 7 hours of last known well: direct transfer to the neurointerventional angiography suite (DTAS) versus conventional emergency department (ED) evaluation before transfer. Patients meeting severity and timing criteria are randomized to either immediate angio-suite workup and possible mechanical thrombectomy or the standard ED imaging and assessment pathway. The primary outcome is functional recovery and disability at 90 days, and secondary outcomes include safety measures such as hemorrhage, quality of life, and time metrics. The trial includes both direct arrivals and interfacility transfers with specific timing rules for eligible participants.
Why it matters
Potential benefit: If successful, bypassing the ED and going straight to the angiography suite could shorten time to treatment and improve recovery and independence after severe LVO stroke.
How similar studies have gone: Some observational studies and a few randomized trials have suggested faster door-to-puncture workflows can improve outcomes, but randomized evidence for routine direct-to-angio routing remains limited and mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: To be eligible for participation in the DIRECT trial, an individual must meet all of the following criteria: 1. Age: ≥ 18 years of age. 2. Clinical Presentation: Present to a participating TSC with signs or symptoms suggestive of acute LVO stroke. 3. Stroke Severity: Baseline NIHSS of 10 or higher. 4. Time since LKW: Time from LKW to arrival at the TSC must be within 7 hours. Additional criteria For all Interfacility Transfers: 1\. If imaging was performed at the outside facility, the time from the first imaging to arrival at the thrombectomy center must exceed 90 minutes. For all the Conventional Triage Arm, participants must also meet the following criteria: 1. Presence of a qualifying LVO by CTA or MRA imaging; or 2. For Large Core Patients: Patients with large core infarcts (CT-ASPECT score ≤ 5, DWI-ASPECT score ≤ 5, or infarct volume ≥ 70 cc) will be enrolled, irrespective of treatment decisions regarding embolectomy. For all DTAS Arm: 1\. Patients who do not have LVO occlusions in the angiography suite assessment (ICH, distal occlusions or mimics) will be enrolled, irrespective of treatment decisions regarding embolectomy. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in the trial: 1. Time Restrictions: Presentation to a thrombectomy-capable center more than 7 hours from LSW. 2. Imaging Criteria for Interfacility Transfer Patients: At sites enrolling transfer patients, any patient arriving from an outside hospital with time from imaging study at the presenting hospital to arrival at the TSC not exceeding 90 minutes. 3. Hemorrhagic Stroke: Presence of intracranial hemorrhage on brain imaging in the conventional strategy as Heidelberg that renders thrombectomy contraindicated.
Where it's running
-
Yale New Haven Hospital
New Haven, Connecticut, United States Recruiting -
Memorial Healthcare System
Hollywood, Florida, United States Recruiting -
University of Miami/ Jackson Memorial Hospital
Miami, Florida, United States Recruiting -
University of Michigan Health-West
Wyoming, Michigan, United States Recruiting -
Saint Louis University
St Louis, Missouri, United States Recruiting -
Cooper University Hospital
Camden, New Jersey, United States Recruiting
Show 9 more locations
-
HMH Hackensack University Medical Center
Hackensack, New Jersey, United States Recruiting -
Rutgers New Jersey Medical School
Newark, New Jersey, United States Recruiting -
The Research Foundation for SUNY on behalf of University at Buffalo
New York, New York, United States Recruiting -
ProMedica Toledo Hospital
Toledo, Ohio, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Texas Tech University Health Sciences Center El Paso
El Paso, Texas, United States Recruiting -
Valley Baptist Medical Center
Harlingen, Texas, United States Recruiting -
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting -
Texas Stroke Institute
Plano, Texas, United States Recruiting
Study contacts
- Principal investigator: Santiago Ortega, MD — University of Iowa
- Study coordinator: Santiago Ortega, MD
- Email: santy-ortega@uiowa.edu
- Phone: 319-384-5628
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of a new neurorehabilitation technology for stroke recovery
This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Endovascular therapy plus standard care vs standard care alone for distal and medium vessel strokes
In people with acute ischemic stroke due to distal or medium vessel blockages, this study tests whether adding endovascular treatment to the usual medical care helps improve outcomes compared with medical care alone.
-
Inter-Limb Transfer after Acute Stroke
This study tests whether practicing motor skills with the affected arm helps improve movement in the other arm after an acute stroke.
-
Immersive Virtual Reality in Upper-Limb Rehabilitation After Stroke
This trial tests whether adding immersive virtual reality to standard upper-limb rehabilitation helps stroke patients recover more function and quality of life.
-
Anakinra After Endovascular Therapy for Ischemic Stroke
This trial tests whether giving two doses of Anakinra after successful endovascular treatment can reduce brain damage and improve outcomes in adults with acute ischemic stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.